Francois Autelitano
Overview
Explore the profile of Francois Autelitano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
70
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bahraoui S, Tejedor G, Mausset-Bonnefont A, Autelitano F, Barthelaix A, Terraza-Aguirre C, et al.
Stem Cell Res Ther
. 2024 Mar;
15(1):70.
PMID: 38454524
Background: Initially discovered for its ability to regenerate ear holes, the Murphy Roth Large (MRL) mouse has been the subject of multiple research studies aimed at evaluating its ability to...
2.
Frank Lee C, Brown C, Nielsen A, Kim C, Livne-Bar I, Parsons P, et al.
Chemistry
. 2022 May;
28(35):e202200360.
PMID: 35491534
Two stereocontrolled, efficient, and modular syntheses of eicosanoid lipoxin B4 (LXB ) are reported. One features a stereoselective reduction followed by an asymmetric epoxidation sequence to set the vicinal diol...
3.
Canovas Nunes S, De Vita S, Anighoro A, Autelitano F, Beaumont E, Klingbeil P, et al.
Blood Cancer J
. 2022 Apr;
12(4):64.
PMID: 35422065
RAS mutations prevalent in high-risk leukemia have been linked to relapse and chemotherapy resistance. Efforts to directly target RAS proteins have been largely unsuccessful. However, since RAS-mediated transformation is dependent...
4.
Tejedor G, Luz-Crawford P, Barthelaix A, Toupet K, Roudieres S, Autelitano F, et al.
Front Cell Dev Biol
. 2021 Mar;
9:579951.
PMID: 33738280
The super healer Murphy Roths Large (MRL) mouse represents the "holy grail" of mammalian regenerative model to decipher the key mechanisms that underlies regeneration in mammals. At a time when...
5.
Brun S, Bassissi F, Serdjebi C, Novello M, Tracz J, Autelitano F, et al.
Invest New Drugs
. 2019 Feb;
37(6):1135-1145.
PMID: 30778887
Among the acquired modifications in cancer cells, changes in lysosomal phenotype and functions are well described, making lysosomes a potential target for novel therapies. Some weak base lipophilic drugs have...
6.
Delcourt N, Quevedo C, Nonne C, Fons P, OBrien D, Loyaux D, et al.
J Biol Chem
. 2014 Nov;
290(6):3405-17.
PMID: 25384978
The formation of new vessels in the tumor, termed angiogenesis, is essential for primary tumor growth and facilitates tumor invasion and metastasis. Hypoxia has been described as one trigger of...
7.
Autelitano F, Loyaux D, Roudieres S, Deon C, Guette F, Fabre P, et al.
PLoS One
. 2014 Nov;
9(10):e110316.
PMID: 25360666
Glioblastoma multiform (GBM) remains clinical indication with significant "unmet medical need". Innovative new therapy to eliminate residual tumor cells and prevent tumor recurrences is critically needed for this deadly disease....